Evidence map›Paper›PMID 31418899›Full record

ArticleThe EMBO journal2019

Interplay between the bacterial protein deacetylase CobB and the second messenger c-di-GMP.

Zhaowei Xu, Hainan Zhang, Xingrun Zhang, Hewei Jiang, Chengxi Liu, Fanlin Wu, Lili Qian, Bingbing Hao, Daniel M Czajkowsky, Shujuan Guo and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Lactate and lactylation in intervertebral disc degeneration.Frontiers in molecular biosciences · 2025
    Review
  7. Article
  8. Review
  9. YkuR functions as a protein deacetylase inProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. A c-di-GMP binding effector controls cell size in a cyanobacterium.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 1 country.

Zhaowei XuKey Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.
Hainan ZhangKey Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.
Xingrun ZhangMOE Key Laboratory of Protein Sciences, Center for Structural Biology, School of Life Sciences, Tsinghua University, Beijing, China.
Hewei JiangKey Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.
Chengxi LiuKey Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.
Fanlin WuKey Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.
Lili QianThe Chemical Proteomics Center and State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Bingbing HaoThe Chemical Proteomics Center and State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Daniel M CzajkowskySchool of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China.
Shujuan GuoKey Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.
Zhijing XuCollege of Life Sciences, Shanghai Normal University, Shanghai, China.
Lijun BiNational Key Laboratory of Biomacromolecules, Key Laboratory of Non-Coding RNA and Key Laboratory of Protein and Peptide Pharmaceuticals, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
Shihua WangSchool of Life Science, Fujian Agriculture and Forestry University, Fuzhou, China.
Haitao LiMOE Key Laboratory of Protein Sciences, Center for Structural Biology, School of Life Sciences, Tsinghua University, Beijing, China.ORCID 0000-0001-6741-293X
Minjia TanThe Chemical Proteomics Center and State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
Wei YanKey Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.
Lei FengInstrumental Analysis Center, Shanghai Jiao Tong University, Shanghai, China.
Jingli HouInstrumental Analysis Center, Shanghai Jiao Tong University, Shanghai, China.
Sheng-Ce TaoKey Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai, China.ORCID 0000-0002-9210-1823
Shanghai Jiao Tong University · CNChinese Academy of Sciences · CNTsinghua University · CNFoshan University · CNFujian Agriculture and Forestry University · CN

Funding

National Basic Research Program of China 2014CBA02004National Natural Science Foundation of China 31370750National Natural Science Foundation of China 31370813National Natural Science Foundation of China 31670066National Natural Science Foundation of China 31670722National Natural Science Foundation of China 31670831National Science & Technology Major Project Key New Drug Creation and Manufacturing Program 2018ZX09711002-004The National Key Research and Development Program of China 2016YFA0500600
6 · The paper itself

Abstract

As a ubiquitous bacterial secondary messenger, c-di-GMP plays key regulatory roles in processes such as bacterial motility and transcription regulation. CobB is the Sir2 family protein deacetylase that controls energy metabolism, chemotaxis, and DNA supercoiling in many bacteria. Using an Escherichia coli proteome microarray, we found that c-di-GMP strongly binds to CobB. Further, protein deacetylation assays showed that c-di-GMP inhibits the activity of CobB and thereby modulates the biogenesis of acetyl-CoA. Interestingly, we also found that one of the key enzymes directly involved in c-di-GMP production, DgcZ, is a substrate of CobB. Deacetylation of DgcZ by CobB enhances its activity and thus the production of c-di-GMP. Our work establishes a novel negative feedback loop linking c-di-GMP biogenesis and CobB-mediated protein deacetylation.

Indexed as

AcetylationAcetyl Coenzyme ACyclic GMPEscherichia coliEscherichia coli ProteinsFeedback, PhysiologicalGene Expression Regulation, BacterialPhosphorus-Oxygen LyasesProtein Array AnalysisProteomicsSecond Messenger SystemsSirtuinsAcetyl Coenzyme Abis(3',5')-cyclic diguanylic acidcobB protein, E ColiCyclic GMPdiguanylate cyclaseEscherichia coli ProteinsPhosphorus-Oxygen LyasesSirtuinsc-di-GMPCobBdiguanylate cyclasenegative feedback loopprotein acetylation

Identifiers

PMID31418899
PMCPMC6745502
OpenAlexW2967487752

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.